Schedule 13G ownership disclosure

RUBIUS THERAPEUTICS INC

Security class unavailable · CUSIP: 78116T103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,710,061
Percent of class
5.8200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001088875-21-000044
Form type
SC 13G/A
Filer
BAILLIE GIFFORD & CO
CIK
CIK 1088875
Filed
Jan 27, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub